Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
QuintilesIMS
Citi
Covington
Colorcon
Fuji
Julphar
Moodys

Generated: December 15, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DOPAMINE HYDROCHLORIDE IN DEXTROSE 5%

« Back to Dashboard

Clinical Trials for Dopamine Hydrochloride In Dextrose 5%

Trial ID Title Status Sponsor Phase Summary
NCT00000276 Dopamine Reuptake Inhibitors of Cocaine Abuse - 1 Terminated National Institute on Drug Abuse (NIDA) Phase 1 The purpose of this study is to evaluate dopamine reuptake inhibitors for cocaine abuse.
NCT00000276 Dopamine Reuptake Inhibitors of Cocaine Abuse - 1 Terminated VA Connecticut Healthcare System Phase 1 The purpose of this study is to evaluate dopamine reuptake inhibitors for cocaine abuse.
NCT00000276 Dopamine Reuptake Inhibitors of Cocaine Abuse - 1 Terminated Yale University Phase 1 The purpose of this study is to evaluate dopamine reuptake inhibitors for cocaine abuse.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Dopamine Hydrochloride In Dextrose 5%

Condition Name

Condition Name for Dopamine Hydrochloride In Dextrose 5%
Intervention Trials
Schizophrenia 90
Parkinson's Disease 64
Parkinson Disease 50
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Dopamine Hydrochloride In Dextrose 5%
Intervention Trials
Parkinson Disease 135
Schizophrenia 95
Disease 67
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Dopamine Hydrochloride In Dextrose 5%

Trials by Country

Trials by Country for Dopamine Hydrochloride In Dextrose 5%
Location Trials
United States 781
Canada 66
Germany 55
France 47
United Kingdom 26
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Dopamine Hydrochloride In Dextrose 5%
Location Trials
New York 70
California 63
Maryland 59
Massachusetts 46
Connecticut 45
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Dopamine Hydrochloride In Dextrose 5%

Clinical Trial Phase

Clinical Trial Phase for Dopamine Hydrochloride In Dextrose 5%
Clinical Trial Phase Trials
Phase 4 155
Phase 3 105
Phase 2/Phase 3 28
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Dopamine Hydrochloride In Dextrose 5%
Clinical Trial Phase Trials
Completed 406
Recruiting 134
Not yet recruiting 63
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Dopamine Hydrochloride In Dextrose 5%

Sponsor Name

Sponsor Name for Dopamine Hydrochloride In Dextrose 5%
Sponsor Trials
National Institute on Drug Abuse (NIDA) 58
National Institute of Mental Health (NIMH) 34
Yale University 25
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Dopamine Hydrochloride In Dextrose 5%
Sponsor Trials
Other 937
Industry 183
NIH 155
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
US Department of Justice
Johnson and Johnson
US Army
Citi
Medtronic
Argus Health
Cipla
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.